Cargando…

Vesicular LL-37 Contributes to Inflammation of the Lesional Skin of Palmoplantar Pustulosis

“Pustulosis palmaris et plantaris”, or palmoplantar pustulosis (PPP), is a chronic pustular dermatitis characterized by intraepidermal palmoplantar pustules. Although early stage vesicles (preceding the pustular phase) formed in the acrosyringium contain the antimicrobial peptides cathelicidin (hCAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Masamoto, Kaneko, Takaaki, Nakatsuji, Teruaki, Kameda, Kenji, Okazaki, Hidenori, Dai, Xiuju, Hanakawa, Yasushi, Tohyama, Mikiko, Ishida-Yamamoto, Akemi, Sayama, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199729/ https://www.ncbi.nlm.nih.gov/pubmed/25330301 http://dx.doi.org/10.1371/journal.pone.0110677

Ejemplares similares

Eccrine Sweat Contains IL-1α, IL-1β and IL-31 and Activates Epidermal Keratinocytes as a Danger Signal
por: Dai, Xiuju, et al.
Publicado: (2013)

Recent advances in palmoplantar pustulosis
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2021)

Palmoplantar pustulosis and IgA nephropathy
por: Shimamura, Yoshinosuke, et al.
Publicado: (2018)

Palmoplantar Pustulosis: A Case Report
por: Dulski, Anne, et al.
Publicado: (2020)

Palmoplantar Pustulosis associated with Membranous Glomerulonephritis
por: Thakur, Vishal, et al.
Publicado: (2021)

A Case of Relapsing Polychondritis with Palmoplantar Pustulosis
por: Kwon, Won Joo, et al.
Publicado: (2016)

Skin-directed radiation therapy for palmoplantar pustulosis
por: King, Brian J., et al.
Publicado: (2019)

Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Guselkumab
por: Jung, Jang Hwan, et al.
Publicado: (2023)

Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis
por: Spencer, Riley K., et al.
Publicado: (2023)

Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
por: Terui, Tadashi, et al.
Publicado: (2019)

The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review
por: Sanchez, Isabelle M., et al.
Publicado: (2017)

Combination biologic therapy for the treatment of severe palmoplantar pustulosis
por: Torre, Kristin M., et al.
Publicado: (2017)

Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments
por: Misiak-Galazka, Magdalena, et al.
Publicado: (2020)

Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis
por: Benzian-Olsson, Natashia, et al.
Publicado: (2020)

Clinical characteristics and associations of palmoplantar pustulosis: an observational study()()
por: Oktem, Ayse, et al.
Publicado: (2020)

Apremilast monotherapy for palmoplantar pustulosis: Report of three cases
por: Marovt, Maruška, et al.
Publicado: (2021)

Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
por: Yamamoto, Toshiyuki
Publicado: (2021)

Relapse of Palmoplantar Pustulosis Following COVID-19 Vaccination
por: Katsuie, Shiho, et al.
Publicado: (2022)

Principal Component Analysis to Differentiate Patients with Palmoplantar Pustulosis from Those with Palmoplantar Pustular Psoriasis
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
por: Heidemeyer, Kristine, et al.
Publicado: (2023)

Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
por: Seol, Jung Eun, et al.
Publicado: (2016)

Palmoplantar Pustulosis-like Eruption Induced by Baricitinib for Treatment of Rheumatoid Arthritis
por: Koumaki, Dimitra, et al.
Publicado: (2019)

Improvement of palmoplantar pustulosis after excision of polyacrylamide injected into the nasal region
por: Kashiyama, Kazuya, et al.
Publicado: (2021)

Design and implementation of an adaptive confirmatory trial in Japanese patients with palmoplantar pustulosis
por: Zheng, Richuan, et al.
Publicado: (2022)

SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
por: Yang, Qingyun, et al.
Publicado: (2022)

Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
por: Shibata, Tomoyuki, et al.
Publicado: (2019)

Efficacy and Safety of Oral Alitretinoin in Hand Eczema and Palmoplantar Pustulosis in Korean Patients
por: Lee, Ji Su, et al.
Publicado: (2019)

Successful treatment of adalimumab-resistant palmoplantar pustulosis with secukinumab: a case report
por: Li, Qing-Yang, et al.
Publicado: (2020)

Immediate response to apremilast in patients with palmoplantar pustulosis: a retrospective pilot study
por: Kato, Noriko, et al.
Publicado: (2021)

Interleukin-19 Levels Are Increased in Palmoplantar Pustulosis and Reduced following Apremilast Treatment
por: Wolk, Kerstin, et al.
Publicado: (2023)

Economic Burden of Palmoplantar Pustulosis in Sweden: A Population-based Register Study
por: LÖFVENDAHL, Sofia, et al.
Publicado: (2023)

Green palmoplantar vesicular eruption in a patient with hyperbilirubinemia
por: Uzoma, Miranda, et al.
Publicado: (2017)

Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study
por: Terui, Tadashi, et al.
Publicado: (2023)

Amicrobial pustulosis of the folds and palmoplantar pustulosis simultaneously induced by different tumor necrosis factor-α inhibitors: Demonstration of a shared pathophysiology
por: Zirwas, Matthew, et al.
Publicado: (2017)

Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study
por: Kromer, Christian, et al.
Publicado: (2019)

Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab
por: Chu, Yuqi, et al.
Publicado: (2022)

CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis
por: Reolid, Alejandra, et al.
Publicado: (2022)

Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
por: Zhang, Chen, et al.
Publicado: (2023)

Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series
por: Xu, Qingqing, et al.
Publicado: (2023)

Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study
por: Burden, A. David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ugjtsr6kksgp96e6ms125omdba